Medistim ASA

10/22/2021 | Press release | Distributed by Public on 10/22/2021 02:21

Results for the Third Quarter 2021

Sales revenues for the quarter ended at MNOK 102.1 (MNOK 83.4), an increase of 22.5%. Sales as of September ended at MNOK 309.2 (MNOK 268.9) a 15.0% increase. Sales in the USA increased by 11.9 % in NOK. Currency neutral growth was 24.9%. Currency neutral sales of own products increased by 33% for the quarter. Operating result (EBIT) for the quarter ended at MNOK 25.1 (MNOK 20.8) a 20.3% increase. EBIT year to date September ended at MNOK 96.8 (MNOK 73.3), a 32.0% increase. This is the best operating result YTD September ever.
Read the full report and presentation below:

Q3 2021 Report

Q3 2021 Presentation